Home › Drug Codes › J Codes › J7210 · AFSTYLA
Updated October 1st, 2026

AFSTYLA J Code: J7210

Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.

Login to unlock all benchmarks
Medicare Payment Limit ?
$1.612
/ HCPCS billing unit
APC Payment Limit ?
$1.612
/ HCPCS billing unit · APC 9043
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
8
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
HCPCS Added Date January 1, 2018
Manufacturer CSL Behring
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Kit | Not Available

About AFSTYLA

Afstyla is a medication aligned to the HCPCS J Code: J7210 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the intravenous route and manufactured by CSL Behring.

According to CMS Drug Use Information: This medication is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding. People with low factor VIII levels are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIII, also called antihemophilic factor. This product is used to temporarily replace the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop. This medication should not be used to treat von Willebrand disease.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 8 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
69911-0474-02 AFSTYLA Antihemophilic Factor (Recombinant), Single Chain CSL Behring Lengnau AG 1 Kit
69911-0475-02 AFSTYLA Antihemophilic Factor (Recombinant), Single Chain CSL Behring Lengnau AG 1 Kit
69911-0476-02 AFSTYLA Antihemophilic Factor (Recombinant), Single Chain CSL Behring Lengnau AG 1 Kit
69911-0477-02 AFSTYLA Antihemophilic Factor (Recombinant), Single Chain CSL Behring Lengnau AG 1 Kit
69911-0478-02 AFSTYLA Antihemophilic Factor (Recombinant), Single Chain CSL Behring Lengnau AG 1 Kit
•••••-••••-•• Log in to view AFSTYLA
AFSTYLA
AFSTYLA
Login to view 3 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

AFSTYLA Pricing & Reimbursement

J7210 Private Payer Reimbursement
$1.44 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

AFSTYLA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Afstyla (J7210) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

AFSTYLA Medically Unlikely Edits (MUE)

The most billing units of J7210 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 iu.

Practitioner Office & Hospital Outpatient
22,000 units / day
= 22,000 iu per day

MAI 1 · Line Edit. Per-line limit: units are checked per claim line; medically necessary units beyond the limit may be billable on separate lines with appropriate modifiers. See all MUE limits →

iu Enter a dose to see how many billing units it is and whether it is under the limit.

AFSTYLA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hemophilia A

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Afstyla billing and coding guide?
Billing and coding information for AFSTYLA can be found through CSL Behring. Visit Here →
Are there any available Afstyla patient assistance programs?
AFSTYLA patient assistance information can be found through CSL Behring. Visit Here →
Where can I find Afstyla prescribing information?
AFSTYLA prescribing information can be found at the link below: Visit Here →
Where can I find Afstyla side effect information?
Our team has not yet identified a source of side effects information for AFSTYLA. Please check back in a few weeks.
Does billing AFSTYLA require JZ/JW wastage modifiers?
CMS has identified AFSTYLA(J7210) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.